Resmed

Resmed

Develops cloud-connected medical devices for chronic diseases

About Resmed

Simplify's Rating
Why Resmed is rated
A-
Rated A on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

Enterprise Software

Healthcare

Company Size

5,001-10,000

Company Stage

IPO

Total Funding

$1.1M

Headquarters

San Diego, California

Founded

1989

Overview

ResMed develops medical devices and software platforms designed to treat and manage conditions like sleep apnea and COPD, as well as other chronic diseases. Their products are cloud-connected, allowing for better monitoring and management of patient health. ResMed's offerings include both medical devices and software subscriptions, which generate revenue through product sales and ongoing service fees. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of care for patients, healthcare professionals, and caregivers. The company's goal is to enhance patient care and quality of life across more than 120 countries.

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing sleep apnea market boosts demand for ResMed's products.
  • Telehealth adoption aligns with ResMed's cloud-connected device strategy.
  • AI integration in healthcare offers innovation opportunities for ResMed.

What critics are saying

  • Increased competition may impact ResMed's market share.
  • Rising raw material costs could squeeze profit margins.
  • Data privacy concerns may lead to regulatory scrutiny.

What makes Resmed unique

  • ResMed offers cloud-connected devices for sleep apnea and chronic disease management.
  • The company operates in over 120 countries, providing a global healthcare solution.
  • ResMed integrates AI in diagnostics, enhancing personalized treatment options.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1.1M

Below

Industry Average

Funded Over

2 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.

MarketBeat
Feb 22nd, 2025
Alberta Investment Management Corp Invests $2.38 Million in ResMed Inc. (NYSE:RMD)

Alberta Investment Management Corp invests $2.38 million in ResMed Inc. (NYSE:RMD).

India Med Today
Jan 10th, 2025
ResMed launches AirSense 11 for sleep apnea patients

ResMed launches airsense 11 for sleep apnea patients.

ResMed
Jan 6th, 2025
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Recently Posted Jobs

Sign up to get curated job recommendations

Resmed is Hiring for 106 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Resmed's jobs every few hours, so check again soon! Browse all jobs →